🇺🇸 FDA
Patent

US 10077232

Cyclic cationic lipids and methods of use

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 10077232 (Cyclic cationic lipids and methods of use) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/7105, A61K31/713, A61K47/18, A61K9/1272